Tetra Bio-Pharma Cancels $10 Million ATM Financing

It appears that Tetra Bio-Pharma (TSX: TBP) has cold feet when it comes to raising money. The company last night announced that it has cancelled its previously announced at-the-market financing.

Originally announced back in May, the financing enabled the company to raise up to $10 million in gross proceeds by directly selling its shares on the open market, with Canaccord acting as sole agent for the process. The company however has elected to terminate the program as of November 11.

Justification for the termination was not provided. Even more curiously, despite the announcement in May, and the fallout in its share price in the time since the announcement, the company has reportedly not sold a single share under the program.

Tetra Bio-Pharma last traded at $0.22 on the TSX.


Information for this briefing was found via Sedar and Tetra Bio-Pharma Inc. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Why Copper Juniors Could Explode After This Trade War Move | Christian Easterday – Hot Chili

Silver Is Rarer Than Gold, And the Market’s Waking Up | Shawn Khunkhun – Dolly Varden Silver

Gold Will Hit North of $4,000: Who’s Actually Producing? | Shane Williams – West Red Lake

Recommended

ESGold Sees ANT Survey Reveal Vertically Continuous System To 1,200 Metres Depth

First Majestic Produces 7.9 Silver Equivalent Ounces In Q2, Lifts Production Guidance

Related News

Hive Blockchain To Raise Another US$100 Million Under At The Market Offering

Hive Blockchain (TSXV: HIVE) is once again raising money. The firm on Friday evening announced...

Sunday, September 4, 2022, 05:13:00 PM

Tetra Bio Pharma Sees Two Products Approved By Health Canada

As The Deep Dive reported on late yesterday afternoon, Tetra Bio Pharma (TSXV: TBP) has...

Friday, January 17, 2020, 09:31:54 AM

Hexo Corp To Conduct ATM Financing To The Tune Of C$150.0 Million

Hexo Corp (TSX: HEXO) (NYSE: HEXO) this morning announced that it will be conducting an...

Tuesday, May 11, 2021, 09:12:54 AM

Bitfarms Announces US$500 Million At The Market Financing, Posts Q2 Net Loss

Last night, Bitfarms Ltd (TSXV: BITF) reported its second quarter financial results, posting revenues of...

Tuesday, August 17, 2021, 08:21:07 AM

Tetra Bio Pharma Sees Product Approved For FDA Fast Track Designation Request

Tetra Bio-Pharma (TSXV: TBP) has received a much anticipated response from the US Food and...

Monday, February 3, 2020, 08:47:08 AM